MJMatti Jantunen

Matti Jantunen

*This is an algorithmically generated author record based on publicly available information.

Matti Jantunen has a total of 279 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Correction to: General Aspects of Exposure Evaluation

    by Christiaan Delmaar, Gerhard Heinemeyer, Matti Jantunen, Klaus Schneider, Michael Schümann

  • Open Access

    City scale climate change policies: Do they matter for wellbeing?

    by Rosemary Hiscock, Arja Asikainen, Jouni Tuomisto, Matti Jantunen, Erkki Pärjälä, Clive E. Sabel


  • Spatial and temporal trends in the mortality burden of air pollution in China: 2004–2012

    by Miaomiao Liu, Yining Huang, Zongwei Ma, Zhou Jin, Xingyu Liu, Haikun Wang, Yang Liu, Jinnan Wang, Matti Jantunen, Jun Bi, et al.


  • Open Access

    Public health impacts of city policies to reduce climate change: findings from the URGENCHE EU-China project

    by Clive E. Sabel, Rosemary Hiscock, Arja Asikainen, Jun Bi, Mike Depledge, Sef van Den Elshout, Rainer Friedrich, Ganlin Huang, Fintan Hurley, Matti Jantunen, et al.

    Climate change is a global threat to health and wellbeing. Here we provide findings of an international research project investigating the health and wellbeing impacts of policies to reduce greenhouse gas emissions in urban environments. Five European and two Chinese city authorities and partner academic organisations formed the project consortium. The methodology involved modelling the impact of adopted urban climate-change mitigation transport, buildings and energy policy scenarios, usually for the year 2020 and comparing them with business as usual (BAU) scenarios (where policies had not been adopted). Carbon dioxide emissions, health impacting exposures (air pollution, noise and physical activity), health (cardiovascular, respiratory, cancer and leukaemia) and wellbeing (including noise related wellbeing, overall wellbeing, economic wellbeing and inequalities) were modelled. The scenarios were developed from corresponding known levels in 2010 and pre-existing exposure response functions. Additionally there were literature reviews, three longitudinal observational studies and two cross sectional surveys. There are four key findings. Firstly introduction of electric cars may confer some small health benefits but it would be unwise for a city to invest in electric vehicles unless their power generation fuel mix generates fewer emissions than petrol and diesel. Second, adopting policies to reduce private car use may have benefits for carbon dioxide reduction and positive health impacts through reduced noise and increased physical activity. Third, the benefits of carbon dioxide reduction from increasing housing efficiency are likely to be minor and co-benefits for health and wellbeing are dependent on good air exchange. Fourthly, although heating dwellings by in-home biomass burning may reduce carbon dioxide emissions, consequences for health and wellbeing were negative with the technology in use in the cities studied. The climate-change reduction policies reduced CO2 emissions (the most common greenhouse gas) from cities but impact on global emissions of CO2 would be more limited due to some displacement of emissions. The health and wellbeing impacts varied and were often limited reflecting existing relatively high quality of life and environmental standards in most of the participating cities; the greatest potential for future health benefit occurs in less developed or developing countries.


  • Open Access

    Building-related health impacts in European and Chinese cities: a scalable assessment method

    by Jouni T. Tuomisto, Marjo Niittynen, Erkki Pärjälä, Arja Asikainen, Laura Perez, Stephan Trüeb, Matti Jantunen, Nino Künzli, Clive E. Sabel


  • Indoor inhalation intake fractions of fine particulate matter: review of influencing factors

    by Natasha Hodas, Miranda Loh, Hyeong‐Moo Shin, Dingsheng Li, Deborah Bennett, Thomas E. McKone, Olivier Jolliet, Charles J. Weschler, Matti Jantunen, Paul Lioy, et al.

    Exposure to fine particulate matter (PM2.5) is a major contributor to the global human disease burden. The indoor environment is of particular importance when considering the health effects associated with PM2.5 exposures because people spend the majority of their time indoors and PM2.5 exposures per unit mass emitted indoors are two to three orders of magnitude larger than exposures to outdoor emissions. Variability in indoor PM2.5 intake fraction (iFin,total), which is defined as the integrated cumulative intake of PM2.5 per unit of emission, is driven by a combination of building-specific, human-specific, and pollutant-specific factors. Due to a limited availability of data characterizing these factors, however, indoor emissions and intake of PM2.5 are not commonly considered when evaluating the environmental performance of product life cycles. With the aim of addressing this barrier, a literature review was conducted and data characterizing factors influencing iFin,total were compiled. In addition to providing data for the calculation of iFin,total in various indoor environments and for a range geographic regions, this paper discusses remaining limitations to the incorporation of PM2.5-derived health impacts into life cycle assessments and makes recommendations regarding future research.


  • Integrated exposure for risk assessment in indoor environments based on a review of concentration data on airborne chemical pollutants in domestic environments in Europe

    by S. Karakitsios, A. Asikainen, C. Garden, S. Semple, K. De Brouwere, K. S. Galea, A. Sánchez-Jiménez, A. Gotti, M. Jantunen, D. Sarigiannis

    This review set out to identify data sets for airborne chemical pollutants measured in domestic dwellings within European Union (EU) countries from the literature published during 1995–2010. A total of 74 papers satisfied inclusion criteria, and from those papers data on country location, population sampled, sampling period, number of samples and summary statistics of concentrations measured were gathered. The chemical substances identified and included were grouped to aldehydes, radon, carbon dioxide (CO2), carbon monoxide (CO), nicotine, nitrogen dioxide (NO2), polycyclic aromatic hydrocarbons, volatile organic compounds and brominated flame retardants. The review showed that the availability of data between the EU countries is varying and more measured data are available for countries in northern Europe than in the southern parts. This review is part of the Integrated Exposure for Risk Assessment in Indoor Environments project which developed a full-chain modelling platform, incorporating tools and databases for indoor chemical source release, exposure and risk assessment with the ultimate aim of estimating the health impact of chemical exposures in the indoor environment.


  • Application of the maximum cumulative ratio (MCR) as a screening tool for the evaluation of mixtures in residential indoor air

    by Katleen De Brouwere, Christa Cornelis, Athanasios Arvanitis, Terry Brown, Derrick Crump, Paul Harrison, Matti Jantunen, Paul Price, Rudi Torfs


  • Top Cited Papers
    Open Access

    Environmental Burden of Disease in Europe: Assessing Nine Risk Factors in Six Countries

    by Otto Hänninen, Anne B. Knol, Matti Jantunen, Tek-Ang Lim, André Conrad, Marianne Rappolder, Paolo Carrer, Anna-Clara Fanetti, Rokho Kim, Jurgen Buekers, et al.

    Background: Environmental health effects vary considerably with regard to their severity, type of disease, and duration. Integrated measures of population health, such as environmental burden of disease (EBD), are useful for setting priorities in environmental health policies and research. This review is a summary of the full Environmental Burden of Disease in European countries (EBoDE) project report. Objectives: The EBoDE project was set up to provide assessments for nine environmental risk factors relevant in selected European countries (Belgium, Finland, France, Germany, Italy, and the Netherlands). Methods: Disability-adjusted life years (DALYs) were estimated for benzene, dioxins, secondhand smoke, formaldehyde, lead, traffic noise, ozone, particulate matter (PM2.5), and radon, using primarily World Health Organization data on burden of disease, (inter)national exposure data, and epidemiological or toxicological risk estimates. Results are presented here without discounting or age-weighting. Results: About 3–7% of the annual burden of disease in the participating countries is associated with the included environmental risk factors. Airborne particulate matter (diameter ≤ 2.5 μm; PM2.5) is the leading risk factor associated with 6,000–10,000 DALYs/year and 1 million people. Secondhand smoke, traffic noise (including road, rail, and air traffic noise), and radon had overlapping estimate ranges (600–1,200 DALYs/million people). Some of the EBD estimates, especially for dioxins and formaldehyde, contain substantial uncertainties that could be only partly quantified. However, overall ranking of the estimates seems relatively robust. Conclusions: With current methods and data, environmental burden of disease estimates support meaningful policy evaluation and resource allocation, including identification of susceptible groups and targets for efficient exposure reduction. International exposure monitoring standards would enhance data quality and improve comparability. Citation: Hänninen O, Knol AB, Jantunen M, Lim TA, Conrad A, Rappolder M, Carrer P, Fanetti AC, Kim R, Buekers J, Torfs R, Iavarone I, Classen T, Hornberg C, Mekel OC, EBoDE Working Group. 2014. Environmental burden of disease in Europe: assessing nine risk factors in six countries. Environ Health Perspect 122:439–446; http://dx.doi.org/10.1289/ehp.1206154